Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Nuala Trainor
Advertisement
Nuala Trainor is director of Biological Programs, Octane Biotech Inc.
Articles by Nuala Trainor
Advertisement
Latest Updated Articles
End-to-End Cell Therapy Automation: An Immunotherapy Case StudyPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Celebrating 20 Years of HPLC-CAD Technology
2
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
3
AstraZeneca Next to Agree to MFN Deal: Report
4
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
5
